[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367026-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367026-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","deep-transfer-learning-links-benign-glands-to-prostate-cancer-progression-via-transcriptomics","Deep Transfer Learning Links Benign Glands to Prostate Cancer Progression via Transcriptomics","","The field effect describes how environmental exposures, infection, and genetic predisposition drive molecular changes that prime cells to develop cancer. High-resolution omics context remains underexplored. Using the Diagnostic Evidence Gauge of Single Cells (DEGAS) deep transfer learning framework on prostate cancer spatial transcriptomics, the study links morphologically benign glands to reduced MSMB expression and programs associated with antigen presentation and aggressive neoplasms, including altered immune-cell infiltration. Immunohistochemistry confirms diminished MSMB (PSP-94) positivity in tissues from patients with 5-year distant metastasis, supporting subtle inflammatory or immune changes as contributors to aggressive progression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/deep-transfer-learning-links-benign-glands-to-prostate-cancer-progression-via-transcriptomics/367026/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/deep-transfer-learning-links-benign-glands-to-prostate-cancer-progression-via-transcriptomics/367026.png","ImageObject",300,407,{"name":42,"@type":43},"MrHarris58","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-09","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the study target in prostate cancer progression?","Question",{"text":63,"@type":64},"It investigates how a “field effect” connects seemingly benign gland regions to later prostate cancer progression, focusing on molecular and immune microenvironment changes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does DEGAS contribute to the analysis?",{"text":68,"@type":64},"DEGAS is used as a deep transfer learning framework to analyze prostate cancer spatial transcriptomics and identify cells and tissues strongly associated with progression.",{"name":70,"@type":61,"acceptedAnswer":71},"What experimental validation is used to support the transcriptomic findings?",{"text":72,"@type":64},"Immunohistochemistry quantifies MSMB protein (PSP-94) expression in morphologically normal and tumor tissues, showing lower positive-cell fractions in patients who developed 5-year distant metastasis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367026,1791462440,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687212988360,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Deep Transfer Learning Links Benign Glands to Prostate Cancer Progression via Transcriptomics  \nJustin L. Couetil 1,2, Ziyu Liu 3, Chao Chen 4, Ahmed K. Alomari 1,5, Kun Huang 1,6,7,8, Jie Zhang 1,7,8, Travis S. Johnson 6,7,8,9, 􀀃  \n1 Department of Medical and Molecular Genetics, IU School of Medicine, Indianapolis, IN 46202, USA 2 Indiana Clinical and Translational Sciences Institute, Indianapolis, IN 46202, USA  \n3 Department of Statistics, Purdue University, West Lafayette, IN 47907, USA  \n4 Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY 11794, USA 5 Department of Pathology, IU School of Medicine, Indianapolis, IN 46202, USA  \n6 Department of Biostatistics and Health Data Sciences, IU School of Medicine, Indianapolis, IN 46202, USA 7 Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN 46202, USA  \n8Center for Computational Biology and Bioinformatics, IU School of Medicine, Indianapolis, IN 46202, USA 9 Indiana Biosciences Research Institute, Indianapolis, IN 46202, USA  \n􀀃 Corresponding author: [johnstrs@iu.edu](johnstrs@iu.edu) (Johnson TS) .  \nHandling Editor: Shihua Zhang  \nAbstract  \nThe field effect describes the phenomena where environmental exposures, infection, and genetic predisposition result in molecular changes in cells that predispose them to developing cancer. Though this is a well-established concept in pathology, it remains underexplored in the context of high-resolution omics. We utilized the Diagnostic Evidence Gauge of Single Cells (DEGAS) deep transfer learning framework to analyze prostate cancer spatial transcriptomics to identify cells and tissues that are highly associated with cancer progression. DEGAS highlighted morphologically benign glands with reduced expression of microseminoprotein-beta ( MSMB), a differentiation marker downregulated in aggressive tumors. These glands have upregulated genes associated with antigen presentation and aggressive neoplasms. Integration of single-cell transcriptomics and deep learning image analysis separately revealed altered immune-cell infiltration, suggesting a complex interplay in the tumor environment, facilitating aggressiveness. We used immunohistochemistry to quantify the MSMB protein (PSP-94) expression in morphologically normal and tumor tissues from patients with and without 5-year distant metastasis. Samples from patients who developed metastasis consistently showed lower fractions of positively stained cells, indicating a subtle yet significant “field effect” in seemingly benign regions. These proteomic results validate the transcriptomic findings and further underscore that inflammatory or immune-related changes in ostensibly normal tissue may contribute to aggressive disease progression.  \nKey words: Spatial transcriptomics; Single-cell transcriptomics; Prostate cancer; Deep learning; Tumor immune microenvironment.  \nReceived: 19 February 2024; Revised: 25 June 2025; Accepted: 24 November 2025.  \n© The Author(s) 2025. Published by Oxford University Press and Science Press on behalf of the Beijing Institute of Genomics, Chinese Academy of Sciences / China National Center for Bioinformation and Genetics Society of China.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.  \n2 Genomics, Proteomics & Bioinformatics, 2025, Vol. 23, No. 6 Graphical abstract  \nIntroduction  \nProstate cancer is the most common malignancy among men in the United States [1]. Fortunately, the 5-year survival rates have improved significantly for localized and regional disease, but it remains the second most common cause of cancer-related deaths [2]. Subsets of patients are much more likely to have a cancer that will spread to distant organs (i.e., metastasis), ","cbCaiovbjnnQpOvu","https://ap.wps.com/l/cbCaiovbjnnQpOvu","pdf",14817547,17,"English","# Abstract\n# Key words\n# Introduction\n## Clinical challenge in prostate cancer risk stratification\n## Limitations of current biomarkers and prognostic modeling\n## Role and limitations of single-cell and spatial multi-omics\n# Received, Revised, Accepted\n# Open access and licensing","[{\"question\":\"What does the study target in prostate cancer progression?\",\"answer\":\"It investigates how a “field effect” connects seemingly benign gland regions to later prostate cancer progression, focusing on molecular and immune microenvironment changes.\"},{\"question\":\"How does DEGAS contribute to the analysis?\",\"answer\":\"DEGAS is used as a deep transfer learning framework to analyze prostate cancer spatial transcriptomics and identify cells and tissues strongly associated with progression.\"},{\"question\":\"What experimental validation is used to support the transcriptomic findings?\",\"answer\":\"Immunohistochemistry quantifies MSMB protein (PSP-94) expression in morphologically normal and tumor tissues, showing lower positive-cell fractions in patients who developed 5-year distant metastasis.\"}]","Deep Transfer Learning Links Benign Glands to Prostate Cancer Progression via Transcriptomics | PDF",1790168860,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73a95a30986045c1ce266d1c97ac78ad.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f86a74e2556a2adb906e1d49ff5f374.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45d3cbbaaadec49edac071cbbfb1dcfc.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd9d28b0683906d7369b010f2f695a9e.webp",980,1287]